|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization (WHO), . Cancer
Fact Sheet 2015. http://www.who.int/mediacentre/factsheets/fs297/en/Accessed.
July 2–2016.
|
|
3
|
Jordan Ministry of Health (MOH), .
National Cancer Registry 2012. simplefile:///C:/Users/ws/Downloads/annual%20report-2012.pdfAccessed.
June 23–2016.
|
|
4
|
Ceschi M, Gutzwiller F, Moch H, Eichholzer
M and Probst-Hensch NM: Epidemiology and pathophysiology of obesity
as cause of cancer. Swiss Med Wkly. 137:50–56. 2007.PubMed/NCBI
|
|
5
|
Davoodi SH, Malek-Shahabi T,
Malekshahi-Moghadam A, Shahbazi R and Esmaeili S: Obesity as an
important risk factor for certain types of cancer. Iran J Cancer
Prev. 6:186–194. 2013.PubMed/NCBI
|
|
6
|
World Health Organization (WHO), . Obesity
and overweight Fact Sheet 2016. http://www.who.int/mediacentre/factsheets/fs311/en/Accessed
on. July 2–2016.
|
|
7
|
Obesity, . Preventing and managing the
global epidemic. Report of a WHO Consultation. World Health Organ
Tech Rep Ser. 894:i-xii. 1–253. 2000.
|
|
8
|
Hillon P, Guiu B, Vincent J and Petit JM:
Obesity, type 2 diabetes and risk of digestive cancer.
Gastroenterol Clin Biol. 34:529–533. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin JH, Gunter MJ, Manson JE, Rexrode KM,
Cook NR, Kraft P, Cochrane BB, Chlebowski RT, Ho GY and Zhang SM:
The aromatase gene (CYP19A1) variants and circulating hepatocyte
growth factor in postmenopausal women. PloS One. 7:e42079.
2012.
|
|
10
|
Fain JN, Madan AK, Hiler ML, Cheema P and
Bahouth SW: Comparison of the release of adipokines by adipose
tissue, adipose tissue matrix and adipocytes from visceral and
subcutaneous abdominal adipose tissues of obese humans.
Endocrinology. 145:2273–2282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vucenik I and Stains JP: Obesity and
cancer risk: Evidence, mechanisms and recommendations. Ann N Y Acad
Sci. 1271:37–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Assiri AM and Kamel HF: Evaluation of
diagnostic and predictive value of serum adipokines: Leptin,
resistin and visfatin in postmenopausal breast cancer. Obes Res
Clin Pract. 10:442–453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alshaker H, Sacco K, Alfraidi A, Muhammad
A, Winkler M and Pchejetski D: Leptin signalling, obesity and
prostate cancer: Molecular and clinical perspective on the old
dilemma. Oncotarget. 6:35556–35563. 2015.PubMed/NCBI
|
|
14
|
Lin T, Zhao X and Kong WM: Association
between adiponectin levels and endometrial carcinoma risk: Evidence
from a dose-response meta-analysis. BMJ Open. 5:e008541. 2015.
View Article : Google Scholar
|
|
15
|
Zhang YW, Su Y, Volpert OV and Woude GF
Vande: Hepatocyte growth factor/scatter factor mediates
angiogenesis through positive VEGF and negative thrombospondin 1
regulation. Proc Natl Acad Sci USA. 100:12718–12723. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scagliotti GV, Novello S and von Pawel J:
The emerging role of MET/HGF inhibitors in oncology. Cancer Treat
Rev. 39:793–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Faber DR, Moll FL, Vink A, van der Waal C,
Kalkhoven E, Schipper HS, Hajer GR, Monajemi H and Visseren FL:
Adipose tissue quantity and composition contribute to adipokine
concentrations in the subclavian vein and the inferior mesenteric
vein. Int J Obes (Lond). 36:1078–1085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hefetz-Sela S and Scherer PE: Adipocytes:
Impact on tumor growth and potential sites for therapeutic
intervention. Pharmacol Ther. 138:197–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging handbook from the AJCC
cancer staging manual. 7th. 2010
|
|
20
|
World HealthOrganization (WHO), .
Circumference and Waist-Hip Ratio: Report of a WHO Expert
Consultation. Geneva: pp. 8–11. 2008
|
|
21
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonen A, Campbell SE, Benton CR, Chabowski
A, Coort SL, Han XX, Koonen DP, Glatz JF and Luiken JJ: Regulation
of fatty acid transport by fatty acid translocase/CD36. Proc Nutr
Soc. 63:245–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong Y, Davis B, Marron JS, Kwitt R, Singh
N, Kimbell JS, Pitkin E, Superfine R, Davis SD, Zdanski CJ and
Niethammer M: Statistical atlas construction via weighted
functional boxplots. Med Image Anal. 18:684–698. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dubois V, Delort L, Billard H, Vasson MP
and Caldefie-Chezet F: Breast cancer and obesity: In vitro
interferences between adipokines and proangiogenic features and/or
antitumor therapies? PloS One. 8:e585412013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Strong AL, Burow ME, Gimble JM and Bunnell
BA: Concise review: The obesity cancer paradigm: Exploration of the
interactions and crosstalk with adipose stem cells. Stem Cells.
33:318–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Silha JV, Krsek M, Sucharda P and Murphy
LJ: Angiogenic factors are elevated in overweight and obese
individuals. Int J Obes (Lond). 29:1308–1314. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moore T, Beltran L, Carbajal S, Hursting
SD and DiGiovanni J: Energy balance modulates mouse skin tumor
promotion through altered IGF-1R and EGFR crosstalk. Cancer Prev
Res (Phila). 5:1236–1246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lear SA, James PT, Ko GT and Kumanyika S:
Appropriateness of waist circumference and waist-to-hip ratio
cutoffs for different ethnic groups. Eur J Clin Nutr. 64:42–61.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alberti KG, Eckel RH, Grundy SM, Zimmet
PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith
SC Jr, et al: Harmonizing the metabolic syndrome: A joint interim
statement of the international diabetes federation task force on
epidemiology and prevention; National heart, lung and blood
institute; American heart association; World heart federation;
International atherosclerosis society; and international
association for the study of obesity. Circulation. 120:1640–1645.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moghaddam AA, Woodward M and Huxley R:
Obesity and risk of colorectal cancer: A meta-analysis of 31
studies with 70,000 events. Cancer Epidemiol Biomarkers Prev.
16:2533–2547. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harvie M, Hooper L and Howell AH: Central
obesity and breast cancer risk: A systematic review. Obes Rev.
4:157–173. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wierup I, Carlsson AC, Wündell P, Riserus
U, Ärnlöv J and Borné Y: Low anthropometric measures and
mortality-results from the Malmö Diet and cancer study. Ann Med.
47:325–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park SW, Lee HL, Doo EY, Lee KN, Jun DW,
Lee OY, Han DS, Yoon BC, Choi HS and Lee KH: Visceral obesity
predicts fewer lymph node metastases and better overall survival in
colon cancer. J Gastrointest Surg. 19:1513–1521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee SA, Kallianpur A, Xiang YB, Wen W, Cai
Q, Liu D, Fazio S, Linton MF, Zheng W and Shu XO: Intra-individual
variation of plasma adipokine levels and utility of single
measurement of these biomarkers in population-based studies. Cancer
Epidemiol Biomarkers Prev. 16:2464–2470. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ayoub NM and Kaddoumi A: Obesity and
breast cancer: Molecular and epidemiological evidence. Journal of
Cancer Research Updates. 4:30–42. 2015. View Article : Google Scholar
|
|
36
|
Giordano C, Vizza D, Panza S, Barone I,
Bonofiglio D, Lanzino M, Sisci D, De Amicis F, Fuqua SA, Catalano S
and Andò S: Leptin increases HER2 protein levels through a
STAT3-mediated up-regulation of Hsp90 in breast cancer cells. Mol
Oncol. 7:379–391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang CY, Yu HS, Lai TY, Yeh YL, Su CC,
Hsu HH, Tsai FJ, Tsai CH, Wu HC and Tang CH: Leptin increases
motility and integrin up-regulation in human prostate cancer cells.
J Cell Physiol. 226:1274–1282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fiorio E, Mercanti A, Terrasi M, Micciolo
R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti
F, et al: Leptin/HER2 crosstalk in breast cancer: In vitro study
and preliminary in vivo analysis. BMC Cancer. 8:305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Alegre MM, Knowles MH, Robison RA and
O'Neill KL: Mechanics behind breast cancer prevention-focus on
obesity, exercise and dietary fat. Asian Pac J Cancer Prev.
14:2207–2212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ray A, Nkhata KJ and Cleary MP: Effects of
leptin on human breast cancer cell lines in relationship to
estrogen receptor and HER2 status. Int J Oncol. 30:1499–1509.
2007.PubMed/NCBI
|
|
41
|
Wang D, Chen J, Chen H, Duan Z, Xu Q, Wei
M, Wang L and Zhong M: Leptin regulates proliferation and apoptosis
of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. J
Biosci. 37:91–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Terrasi M, Bazan V, Caruso S, Insalaco L,
Amodeo V, Fanale D, Corsini LR, Contaldo C, Mercanti A, Fiorio E,
et al: Effects of PPARγ agonists on the expression of leptin and
vascular endothelial growth factor in breast cancer cells. J Cell
Physiol. 228:1368–1374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Du J, Han JC, Zhang YJ, Qi GB, Zhang Y and
Li HB: Relationship between serum leptin levels and non-small cell
lung carcinoma: A meta-analysis. Genet Mol Res. 14:13699–13708.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Grossmann ME and Cleary MP: The balance
between leptin and adiponectin in the control of
carcinogenesis-focus on mammary tumorigenesis. Biochimie.
94:2164–2171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stolzenberg-Solomon RZ, Newton CC,
Silverman DT, Pollak M, Nogueira LM, Weinstein SJ, Albanes D,
Männistö S and Jacobs EJ: Circulating leptin and risk of pancreatic
cancer: A pooled analysis from 3 cohorts. Am J Epidemiol.
182:187–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gong TT, Wu QJ, Wang YL and Ma XX:
Circulating adiponectin, leptin and adiponectin-leptin ratio and
endometrial cancer risk: Evidence from a meta-analysis of
epidemiologic studies. Int J Cancer. 137:1967–1978. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Obeid S and Hebbard L: Role of adiponectin
and its receptors in cancer. Cancer Biol Med. 9:213–220.
2012.PubMed/NCBI
|
|
48
|
Shin E, Yu YD, Kim DS and Won NH:
Adiponectin receptor expression predicts favorable prognosis in
cases of hepatocellular carcinoma. Pathol Oncol Res. 20:667–675.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dalamaga M, Diakopoulos KN and Mantzoros
CS: The role of adiponectin in cancer: A review of current
evidence. Endocr Rev. 33:547–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Delort L, Jardé T, Dubois V, Vasson MP and
Caldefie-Chezet F: New insights into anticarcinogenic properties of
adiponectin: A potential therapeutic approach in breast cancer?
Vitam Horm. 90:397–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Vona-Davis L and Rose DP: Adipokines as
endocrine, paracrine, and autocrine factors in breast cancer risk
and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Otvos L Jr, Haspinger E, La Russa F,
Maspero F, Graziano P, Kovalszky I, Lovas S, Nama K, Hoffmann R,
Knappe D, et al: Design and development of a peptide-based
adiponectin receptor agonist for cancer treatment. BMC Biotechnol.
11:90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee CH, Woo YC, Wang Y, Yeung CY, Xu A and
Lam KS: Obesity, adipokines and cancer: An update. Clin Endocrinol
(Oxf). 83:147–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dalamaga M: Obesity, insulin resistance,
adipocytokines and breast cancer: New biomarkers and attractive
therapeutic targets. World J Exp Med. 3:34–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rehman J, Traktuev D, Li J, Merfeld-Clauss
S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV
and March KL: Secretion of angiogenic and antiapoptotic factors by
human adipose stromal cells. Circulation. 109:1292–1298. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Stein GY, Yosef N, Reichman H, Horev J,
Laser-Azogui A, Berens A, Resau J, Ruppin E, Sharan R and Tsarfaty
I: Met kinetic signature derived from the response to HGF/SF in a
cellular model predicts breast cancer patient survival. PloS One.
7:e45969. 2012. View Article : Google Scholar
|
|
57
|
Tang Z, Du R, Jiang S, Wu C, Barkauskas
DS, Richey J, Molter J, Lam M, Flask C, Gerson S, et al: Dual
MET-EGFR combinatorial inhibition against T790M-EGFR-mediated
erlotinib-resistant lung cancer. Br J Cancer. 99:911–922. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sattler M and Salgia R: The MET axis as a
therapeutic target. Update Cancer Ther. 3:109–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lawrence RE and Salgia R: MET molecular
mechanisms and therapies in lung cancer. Cell Adh Migr. 4:146–152.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Rehman J, Considine RV, Bovenkerk JE, Li
J, Slavens CA, Jones RM and March KL: Obesity is associated with
increased levels of circulating hepatocyte growth factor. J Am Coll
Cardiol. 41:1408–1413. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Faber DR, van der Graaf Y, Westerink J,
Kanhai DA, Monajemi H and Visseren FL: SMART study Group:
Hepatocyte growth factor and interferon-γ inducible protein-10 are
related to visceral adiposity. Eur J Clin Invest. 43:369–378. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Karapanagiotou EM, Tsochatzis EA, Dilana
KD, Tourkantonis I, Gratsias I and Syrigos KN: The significance of
leptin, adiponectin, and resistin serum levels in non-small cell
lung cancer (NSCLC). Lung cancer. 61:391–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Slomian G, Swietochowska E,
Malinowska-Borowska J, Kasperczyk S, Rogalska A and Nowak P:
Association between chemotherapy and plasma adipokines in patients
with colorectal cancer. Pharmacol Rep. 66:902–907. 2014. View Article : Google Scholar : PubMed/NCBI
|
